Cell Line Development Market Growth and Forecast To 2031
The cell line development market was valued at US$ 6.86 billion in 2023 and is expected to reach US$ 18.62 billion by 2031. The market is expected to register a CAGR of 13.3% in 2023–2031. Ongoing advancements in cell line engineering and robust development in cell line technology will likely remain key cell line development market trends.
Cell Line Development Market Analysis
Developing cell lines is crucial for assessing toxicity, in-vitro testing, and the effectiveness of discovering new medications. This procedure lowers the chance of medication failure during clinical trials by saving money, time, and effort. Recombinant proteins are generated throughout the cell line development procedure. These include vaccines, fusion proteins, growth factors, enzymes, bi-specific and monoclonal antibodies, and novel approaches to creating immunotherapies for cancer treatment. Researchers seek ways to move through the early stages of biotherapeutic discovery and candidate selection to reduce the costs associated with cell line development. This process is efficient because it quickly produces and selects cell lines that yield high-quality recombinant protein in large quantities and removes clone candidates that are likely to fail as soon as feasible. Technological developments in cell line development have accelerated the testing of different drug candidates in the early phases of development, saving time and money.
Additionally, businesses engaged in drug discovery and cell line development have been cooperating, expanding the sector. For example, Cytiva recently purchased CEVEC Pharmaceuticals, a top German technology supplier for producing viral vectors and high-performance cell lines. Bio-Techne Corporation declared in July 2022 that Namocell, Inc. had been fully acquired. Simple single-cell sorting and dispensing platforms that protect cell viability and integrity are made available by the Namocell acquisition. In numerous workflows in biotherapeutics and diagnostics, such as developing and commercializing cell and gene therapies, cell engineering, cell line development, single-cell genomics, antibody discovery, synthetic biology, and rare cell isolation, Namocell's tools and consumables are essential technologies.
Cell Line Development Market Overview
The process of choosing the cellular machinery to produce therapeutic biologics or other interesting proteins is called cell line development. Yeast, mammals, plants, and bacteria can use several expression systems to develop cell lines. Chinese hamster ovary (CHO) cells cultivated in suspension cultures are most frequently used to produce the complex protein. These cells are eventually used in bioreactors during the manufacturing stage. Small-scale suspension cultures are the first step in developing cell lines, eventually moving to large-scale bioreactors during manufacturing. The application of cell lines to generate therapeutic products transforms every aspect of the biopharmaceutical industry, from creating innovative gene therapies to producing state-of-the-art vaccines and cancer-fighting medications. This, in turn, creates significant opportunity in the market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell Line Development Market: Strategic Insights
Market Size Value in US$ 4,160.42 Million in 2019 Market Size Value by US$ 11,219.87 Million by 2027 Growth rate CAGR of 13.3% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell Line Development Market: Strategic Insights
| Market Size Value in | US$ 4,160.42 Million in 2019 |
| Market Size Value by | US$ 11,219.87 Million by 2027 |
| Growth rate | CAGR of 13.3% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Cell Line Development Market Drivers and Opportunities
Rise in Production of Vaccine to Favor Market
Many methods for producing large amounts of antigenic proteins have had to be developed in response to the increasing demand for vaccine products. Vaccine developers typically adhere to a linear process that includes thorough data analysis and verification to guard against historically high failure rates. Prominent producers of vaccines and antiviral medications are putting a lot of effort into creating new approaches to producing pandemic candidates and seasonal influenza vaccines. Until recently, most efforts have gone toward developing licensed egg-based vaccines. To meet the demands of the upcoming seasonal campaign and to produce pandemic vaccine prototypes for clinical trials, manufacturers have been focusing on increasing production capacities and automating parts of largely manual steps in egg-based vaccine technology. Thus, an increase in the production of vaccines is likely to drive the growth of the cell line development market.
Significant Opportunities in Emerging Market – An Opportunity in the Cell Line Development Market
Cell lines are needed for production because biologics and biosimilars are receiving more attention. Research and development opportunities in this field can be made possible through partnerships with government initiatives, biotech companies, and academic institutions. Furthermore, India is desirable for cell line development activities due to its highly skilled workforce and cheaper development costs than Western nations. For instance, through national funding organizations like the Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), and the Department of Science and Technology (DST), the government supports the development of cell lines in developing nations like India.
Cell Line Development Market Report Segmentation Analysis
Key segments contributing to the cell line development market analysis derivation are type, product, and application.
- Based on type, the cell line development market is segmented into primary cell line, hybridomas, continuous cell lines, recombinant cell line. The recombinant cell line segment held a larger market share in 2023.
- By product, the market is segmented into equipment, media, reagent. The media & reagent segment held the largest share of the market in 2023.
- By application, the market is segmented into drug discovery, bioproduction, tissue engineering. The bioproduction segment held the largest share of the market in 2023.
Cell Line Development Market Share Analysis by Geography
The cell line development market report's geographic scope is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
North America has dominated the cell line development market. In North America, the US is the largest market for cell line development in 2023. The expansion of the US cell line development market is attributed to the different players in the industry, and the dynamic conditions established in this area have changed the dynamics of cell line development in the area. Key players in the market, a lot of research and development being done by different academic and research institutes, and a growing demand for novel products from biopharmaceutical and biotechnology companies are growth characteristics in North America. Furthermore, significant funding for genomic research from public and private entities, along with growing emphasis on the integration of advanced methods in healthcare and government and private initiatives to promote precision medicine, are anticipated to propel growth and generate exceptional revenue for the North American cell line development market. Due to numerous development initiatives and business plans that support the creation, discovery, or modification of diverse biomolecules and organisms through bioengineering techniques, medical biotechnology has experienced revolutions. The nation's new businesses with exciting and creative ideas have benefited from the Biotech Startup Revolution, which has also helped maximize revenue generation and North America's economic standing in the international cell line development market.
Cell Line Development Market Report Scope
Cell Line Development Market News and Recent Developments
The cell line development market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for cell line development and strategies:
- Abzena announced on Jan. 16, 2023 the launch of AbZelect and AbZelectPRO, its new cell line development (CLD) platforms, designed to speed up the generation of production cell lines for the manufacture of antibodies and recombinant proteins. The platforms are intended to enable the rapid progress of complex biologic drug programs towards clinical trials and investigational new drug (IND) application filing. (Source: Abzena Company Name, Newletter, 2023)
- Lonza announced the launch of its new GS Effex cell line for the development of therapeutic antibodies with enhanced potency. The GS Effex cell line was developed to meet pressing market needs originating from the shift towards more sophisticated therapeutic antibodies. Derived from Lonza’s leading GS Xceed cell line, GS Effex fits effectively into Lonza platforms. Combined with good cell growth and the ability to produce therapeutic antibodies with increased potency, the new cell line provides a solution for therapeutic development from discovery stage research through to commercial manufacturing. (Source: Lonza Company Name, Press Release, 2023)
Cell Line Development Market Report Coverage and Deliverables
The “Cell Line Development Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ; By Product ; Application ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For